OASMY Oasmia Pharmaceutical AB ADR
- 0.020000
- 0.0000000.00%
Oasmia Pharmaceutical AB ADR News
Oasmia Pharmaceutical AB ADR | 424B3: Prospectus
Oasmia Pharmaceutical AB ADR | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Oasmia Pharmaceutical AB ADR | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Oasmia Pharmaceutical AB ADR | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Oasmia Pharmaceutical AB ADR | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Oasmia Pharmaceutical AB ADR | 20-F: FY2018 Annual Report
Oasmia Pharmaceutical AB ADR | CORRESP: CORRESP
Oasmia Pharmaceutical AB ADR | UPLOAD: Others
Oasmia Pharmaceutical AB ADR | UPLOAD: Others
Oasmia Pharmaceutical AB ADR | CORRESP: CORRESP
Oasmia Pharmaceutical AB ADR | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Oasmia Pharmaceutical AB ADR | CORRESP: CORRESP
Oasmia Pharmaceutical AB ADR | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Oasmia Pharmaceutical AB ADR | UPLOAD: Others
Oasmia Pharmaceutical AB ADR | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Oasmia Pharmaceutical AB ADR | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Oasmia Pharmaceutical AB ADR | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Oasmia Pharmaceutical AB ADR | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Oasmia Pharmaceutical AB ADR | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Oasmia Pharmaceutical AB ADR | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Analysis
Price Target
No Data
